Παρακολούθηση
Catherine Voegele
Catherine Voegele
International Agency for Research on Cancer (IARC/WHO)
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα iarc.who.int
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Rare mutations in XRCC2 increase the risk of breast cancer
DJ Park, F Lesueur, T Nguyen-Dumont, M Pertesi, F Odefrey, F Hammet, ...
The American Journal of Human Genetics 90 (4), 734-739, 2012
2282012
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer
SV Tavtigian, PJ Oefner, D Babikyan, A Hartmann, S Healey, ...
The American Journal of Human Genetics 85 (4), 427-446, 2009
2202009
Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus
S Garritano, F Gemignani, C Voegele, T Nguyen-Dumont, ...
BMC genetics 10, 1-12, 2009
1912009
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
N Alcala, N Leblay, AAG Gabriel, L Mangiante, D Hervás, T Giffon, ...
Nature communications 10 (1), 3407, 2019
1712019
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family …
F Damiola, M Pertesi, J Oliver, F Le Calvez-Kelm, C Voegele, EL Young, ...
Breast Cancer Research 16, 1-16, 2014
1452014
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
DF Easton, F Lesueur, B Decker, K Michailidou, J Li, J Allen, C Luccarini, ...
Journal of medical genetics 53 (5), 298-309, 2016
1442016
Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice
D Viarisio, K Müller-Decker, R Accardi, A Robitaille, M Dürst, K Beer, ...
PLoS pathogens 14 (1), e1006783, 2018
1232018
Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing
D Degli Esposti, H Hernandez-Vargas, C Voegele, N Fernandez-Jimenez, ...
Oncotarget 7 (22), 31862, 2016
972016
Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control …
F Le Calvez-Kelm, F Lesueur, F Damiola, M Vallée, C Voegele, ...
Breast Cancer Research 13, 1-12, 2011
962011
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study
MI Hosen, M Sheikh, M Zvereva, G Scelo, N Forey, G Durand, C Voegele, ...
EBioMedicine 53, 2020
742020
Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
PH Avogbe, A Manel, E Vian, G Durand, N Forey, C Voegele, M Zvereva, ...
EBioMedicine 44, 431-438, 2019
642019
Rare Mutations in RINT1 Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
DJ Park, K Tao, F Le Calvez-Kelm, T Nguyen-Dumont, N Robinot, ...
Cancer discovery 4 (7), 804-815, 2014
632014
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma
C Vinayanuwattikun, F Le Calvez-Kelm, B Abedi-Ardekani, D Zaridze, ...
Scientific reports 6 (1), 31628, 2016
522016
RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study
F Le Calvez-Kelm, J Oliver, F Damiola, N Forey, N Robinot, G Durand, ...
PLoS One 7 (12), e52374, 2012
462012
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
L Mangiante, N Alcala, A Sexton-Oates, A Di Genova, A Gonzalez-Perez, ...
Nature Genetics 55 (4), 607-618, 2023
452023
Multigene testing of moderate-risk genes: be mindful of the missense
EL Young, BJ Feng, AW Stark, F Damiola, G Durand, N Forey, TC Francy, ...
Journal of Medical Genetics 53 (6), 366-376, 2016
452016
A Laboratory Information Management System (LIMS) for a high throughput genetic platform aimed at candidate gene mutation screening
C Voegele, SV Tavtigian, D De Silva, S Cuber, A Thomas, ...
Bioinformatics 23 (18), 2504-2506, 2007
442007
Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer
MI Hosen, N Forey, G Durand, C Voegele, S Bilici, PH Avogbe, ...
Cancers 12 (12), 3541, 2020
362020
Low-coverage exome sequencing screen in formalin-fixed paraffin-embedded tumors reveals evidence of exposure to carcinogenic aristolochic acid
X Castells, S Karanović, M Ardin, K Tomić, E Xylinas, G Durand, S Villar, ...
Cancer Epidemiology, Biomarkers & Prevention 24 (12), 1873-1881, 2015
312015
Epstein-Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α
R Accardi, I Fathallah, H Gruffat, G Mariggiò, F Le Calvez-Kelm, ...
PLoS pathogens 9 (3), e1003186, 2013
312013
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20